Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SMS PharmaceuticalsNSE:SMSPHARMA -2.77%78 Days Payable is 83.23 as of Jun. 2026, which is 25% above its 10-year median of 66.66. GuruFocus rates NSE:SMSPHARMA with a GF Score™ of 78/100 and a GF Value™ of ₹278.49 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, SMS Pharmaceuticals ranks worse than 57.71% on this metric.
The historical rank and industry rank for SMS Pharmaceuticals's Days Payable or its related term are showing as below:
NSE:SMSPHARMA'
s Days Payable Range Over the Past 10 Years
Min: 48.46 Med: 66.66 Max: 94.88
Current: 77.17
During the past 13 years, SMS Pharmaceuticals's highest Days Payable was 94.88. The lowest was 48.46. And the median was 66.66.
NSE:SMSPHARMA's Days Payable is ranked worse than 57.71% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.28
vs NSE:SMSPHARMA: 77.17
SMS Pharmaceuticals's Days Payable
increased
from Jun. 2025 (79.53) to Jun. 2026 (83.23).
It may suggest that SMS Pharmaceuticalsdelayed paying its suppliers.
The historical data trend for SMS Pharmaceuticals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:SMSPHARMA vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, SMS Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMS Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SMS Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where SMS Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
SMS Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMS Pharmaceuticals (NSE:SMSPHARMA) has a Days Payable of 83.23 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SMS Pharmaceuticals and its competitors. This is 25% above median its historical median of 66.66. Over the past decade, SMS Pharmaceuticals' Days Payable has ranged from 48.46 to 94.88. According to the industry distribution chart, SMS Pharmaceuticals ranks #535 out of 927 companies in the Drug Manufacturers industry, placing it in the top 57.7%.
Is SMS Pharmaceuticals' Days Payable too high?
SMS Pharmaceuticals' current Days Payable of 83.23 is 25% above median its 10-year median of 66.66. Over the past 10 years, this metric has ranged from a low of 48.46 to a high of 94.88. The Drug Manufacturers industry median Days Payable is 90.28. SMS Pharmaceuticals' value of 83.23 is 7.8% below this industry median. Based on the distribution chart, SMS Pharmaceuticals ranks #535 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, SMS Pharmaceuticals has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SMS Pharmaceuticals' Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, SMS Pharmaceuticals ranks #535 out of 927 companies for Days Payable. This places SMS Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 90.28. SMS Pharmaceuticals' value of 83.23 is 7.8% below this benchmark. Historically, SMS Pharmaceuticals' own Days Payable has ranged from 48.46 to 94.88 over the past decade. While the company's 10-year median is 66.66 vs. the industry median of 90.28, SMS Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.28, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMS Pharmaceuticals's current Days Payable of 83.23 is 7.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on SMS Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMS Pharmaceuticals's current Days Payable is 83.23, which is 25% above median its own 10-year median of 66.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMS Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SMS Pharmaceuticals (NSE:SMSPHARMA) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹278.49, compared to a current price of ₹363.55 — trading 30.5% above its estimated fair value. The current Days Payable is 83.23, which is 25% above median its 10-year median of 66.66 and 7.8% below the Drug Manufacturers industry median of 90.28. SMS Pharmaceuticals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For SMS Pharmaceuticals (NSE:SMSPHARMA), the current Days Payable is 83.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMS Pharmaceuticals (NSE:SMSPHARMA) Overvalued in 2026?
Based on GuruFocus' analysis, SMS Pharmaceuticals stock appears to be overvalued.
The current stock price of ₹363.55 is trading 30.5% above its estimated GF Value™ of ₹278.49.
GuruFocus considers SMS Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for NSE:SMSPHARMA:
Days Payable: 83.23 (25% above median its 10-year median of 66.66)
GF Value™: ₹278.49 vs. price of ₹363.55 (30.5% above fair value)
Industry Position: 7.8% below the Drug Manufacturers median (#535 of 927)
No single metric tells the full story. See the NSE:SMSPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SMS Pharmaceuticals Ltd is a drug manufacturing company. It is engaged in the business of manufacturing Active Pharma Ingredients and their intermediates. Its product portfolio includes drugs for anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, anti-viral, and other conditions.
78GF Score
Get the complete analysis for NSE:SMSPHARMA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SMSPHARMA has been successfully added to your 
